Journals / Türk Kadın Sağlığı ve Neonatoloji Dergisi / 2021 / Cilt: 3 - Sayı: 3

Screening for COVID-19 in asymptomatic pregnant women: Which is better; rectal or oropharyngeal/nasopharyngeal swab?

Asemptomatik gebe kadınlarda COVID-19 taraması: Hangisi daha iyi; rektal mi orofaringeal / nazofaringeal sürüntü mü?

Pages
54–59
Publication Date
2021-09-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

No evidence was found about the intrauterinetransmission of asymptomatic disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The aim of the study was to evaluate the incidence of asymptomatic COVID-19 disease in pregnant women withrectal and oropharyngeal/nasopharyngeal swab to compare the efficacy of two samples.Material and Method: This prospective cohort study included 234 asymptomatic pregnant women who had undergoneplanned cesarean section between May 7 and September 24, 2020 in obstetrics unit of a tertiary care center, in Ankara,Turkey.
📊
Key Findings & Data:The real-time reverse transcriptase-polymerase chainreaction (RT-PCR) test was performed to detect SARS-CoV-2 virus in the samples.Results: The incidence of the asymptomatic COVID-19 disease was 0.42% (1/234) in the study population.
💡
Conclusion & Impact:No evidence was found about the intrauterinetransmission of asymptomatic disease.
🔬Design:Research Article
📍Scope:2020 Verileri
⚙️Variables:COVID-19 · SARS-CoV-2 · koronavirüs

Abstract

Aim: The aim of the study was to evaluate the incidence of asymptomatic COVID-19 disease in pregnant women withrectal and oropharyngeal/nasopharyngeal swab to compare the efficacy of two samples.Material and Method: This prospective cohort study included 234 asymptomatic pregnant women who had undergoneplanned cesarean section between May 7 and September 24, 2020 in obstetrics unit of a tertiary care center, in Ankara,Turkey. The oropharyngeal/nasopharyngeal swab, rectal swab, placental, amniotic fluid, and cord blood samples wereobtained from all participants. The placental, amniotic fluid, and cord blood samples were tested when any of theoropharyngeal/nasopharyngeal or rectal samples were positive. The real-time reverse transcriptase-polymerase chainreaction (RT-PCR) test was performed to detect SARS-CoV-2 virus in the samples.Results: The incidence of the asymptomatic COVID-19 disease was 0.42% (1/234) in the study population. One of 234oropharyngeal/nasopharyngeal swabs was positive, while none of the rectal swabs including the one positive withoropharyngeal/nasopharyngeal swab were positive for SARS-CoV-2 virus. The RT-PCR test results of the placental,amniotic fluid, and cord blood samples of the COVID-positive case were negative.Conclusion: The incidence of asymptomatic COVID-19 disease in pregnant women who had undergone elective cesareandelivery was low, in Ankara, Turkey. In asymptomatic pregnant women, oropharyngeal/nasopharyngeal swab was foundto be more useful in detecting COVID-19 disease compared to rectal swab. No evidence was found about the intrauterinetransmission of asymptomatic disease.

Özet

Amaç: Çalışmanın amacı, rektal ve orofaringeal / nazofaringeal sürüntü ile gebelerde asemptomatik COVID-19 hastalıkinsidansını değerlendirerek iki yöntemin etkinliğini karşılaştırmaktı.Gereç ve Yöntem: Bu prospektif kohort çalışmasına, Ankara'da üçüncü basamak bir merkezin obstetri ünitesinde 7Mayıs-24 Eylül 2020 tarihleri arasında planlı sezaryen yapılan 234 asemptomatik gebe dahil edildi. Tüm katılımcılardanorofaringeal / nazofaringeal sürüntü, rektal sürüntü, plasental, amniyotik sıvı ve kordon kanı örnekleri alındı. Orofaringeal/ nazofaringeal veya rektal örneklerden herhangi biri pozitif olduğunda plasental, amniyotik sıvı ve kordon kanı örnekleritest edildi. Örneklerdeki SARS-CoV-2 virüsünü tespit etmek için gerçek zamanlı ters transkriptaz-polimeraz zincirreaksiyonu (RT-PCR) testi yapıldı.Bulgular: Asemptomatik COVID-19 hastalık insidansı çalışma popülasyonunda % 0,42 (1/234) idi. 234 orofaringeal /nazofaringeal sürüntüden biri pozitif iken, orofaringeal / nazofaringeal sürüntü ile pozitif olan dahil rektal sürüntülerinhiçbiri SARS-CoV-2 virüsü için pozitif değildi. COVID pozitif olgunun plasental, amniyotik sıvı ve kordon kanı örneklerininRT-PCR testi sonuçları negatifti.Sonuç: Ankara'da elektif sezaryen ile doğum yapmış gebelerde asemptomatik COVID-19 hastalığı insidansı düşüktü.Asemptomatik hamile kadınlarda, orofaringeal / nazofaringeal sürüntü rektal sürüntü ile karşılaştırıldığında COVID-19hastalığını tespit etmede daha yararlı bulundu. Asemptomatik hastalığın intrauterin geçişine dair bir kanıt bulunamadı.

🔖

Cite This Article

KINAY, T., AKPINAR, F., REİS, Y. A., ÖZKAYA, E., DURMAZ, R., USTUN, Y. (2021). Screening for COVID-19 in asymptomatic pregnant women: Which is better; rectal or oropharyngeal/nasopharyngeal swab?. Türk Kadın Sağlığı ve Neonatoloji Dergisi, Cilt: 3 - Sayı: 3, 54–59. https://ajindex.com/articles/811663

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. WHO. Rolling updates on coronavirus disease (COVID-19). 2020. Available at.Accesion date: December 3, 2020
  2. Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA. 2020;323:1061-1069.
  3. Wong S, Chow K, Leung T, et al. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol 2004; 191:292-297.
  4. Alfaraj SH, Al-Tawfiq JA, Memish ZA. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection during pregnancy: report of two cases & review of the literature. J Microbiol Immunol Infect 2019; 52:501-503.
  5. Ryan GA, Purandare NC, McAuliffe FM, Hod M, Purandare CN. Clinical update on COVID-19 in pregnancy: A review article. J Obstet Gynaecol Res 2020; 46:1235-1245.
  6. Damar Çakırca T, Torun A, Hamidanoğlu M, et al. COVID-19 infection in pregnancy: a single center experience with 75 cases. Ginekol Pol 2021; doi: 10.5603/GP.a2021.0118. Epub ahead of print. PMID: 34263921. Fassett MJ, Lurvey LD, Yasumura L,et al. Universal SARS-Cov-2 Screening in Women Admitted for Delivery in a Large Managed Care Organization. Am J Perinatol 2020; 37:1110-1114.
  7. Herraiz I, Folgueira D, Villalaín C, Forcén L, Delgado R, Galindo A. Universal screening for SARS-CoV-2 before labor admission during Covid-19 pandemic in Madrid. J Perinat Med 2020; 48:981-984.
  8. Prabhu M, Cagino K, Matthews KC,et al. Pregnancy and postpartum outcomes in a universally tested population for SARSCoV-2 in New York City: a prospective cohort study. BJOG.2020; 127:1548-1556.
  9. Figueiredo R, Tavares S, Moucho M, Ramalho C. Systematic screening for SARS-CoV-2 in pregnant women admitted for delivery in a Portuguese maternity J Perinat Med 2020; 48:977-980.
  10. Yassa M, Yirmibes C, Cavusoglu G,et al. Outcomes of universal SARS-CoV-2 testing program in pregnant women admitted to hospital and the adjuvant role of lung ultrasound in screening: a prospective cohort study. J Matern Fetal Neonatal Med 2020; 33:3820-3826.
  11. London V, McLaren R Jr, Atallah F,et al. The Relationship between Status at Presentation and Outcomes among Pregnant Women with COVID-19. Am J Perinatol 2020; 37:991-994.
  12. Sutton D, Fuchs K, D'Alton M, Goffman D. Universal Screening for SARS-CoV-2 in Women Admitted for Delivery. N Engl J Med 2020; 382:2163-2164.
  13. Chiofalo B, Baiocco E, Mancini E,et al. Practical recommendations for gynecologic surgery during the COVID-19 pandemic. Int J Gynaecol Obstet 2020; 150:146-150. World Heal